Caris Life Sciences Partners with Everlywell to Launch Caris’ Forthcoming MCED Assay, Caris Detect
Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced a partnership with Everlywell, a digital health company pioneering the next generation of biomarker intelligence, combining AI-powered technology with human insight to deliver personalized, actionable health answers. Caris and Everlywell are partnering to launch Caris Detect(TM), Caris’ […]